In-vitro Colorectal Cancer Screening Tests Market size over $903mn by 2023

1
In-vitro Colorectal Cancer Screening Tests Market
size over 903mn by 2023 Global Market Insights
Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from In-vitro Colorectal Cancer
Screening Tests Market

• Global in-vitro colorectal cancer screening tests
  market size was USD 599.8 million in 2015, with
  USD 903.1 million revenue expectation by 2023.
• North America, with U.S. in-vitro colorectal
  cancer screening tests market dominating regional
  revenue, accounted of 46 of 2015 sales.
• Germany in-vitro colorectal cancer screening
  tests market looks set to surpass USD 60 million
  by 2023, at 5.8 CAGR.
• Fecal occult blood tests dominated the global
  in-vitro colorectal cancer screening market in
  2015, with over USD 500 million in revenue.  

3
Continued...

• New entrant threat is expected to remain low
  throughout forecast period. High research and
  development investments entailing the
  introduction of new products, and stringent FDA
  regulations are expected to elevate the barrier
  for new entrants.
• Presence of untapped opportunities in emerging
  markets of India, China, Malaysia, South Korea,
  and Brazil are expected to offer potential growth
  opportunities.
• Increasing per capita healthcare spending,
  disposable income levels in these countries and
  rising awareness regarding early diagnosis of
  colorectal cancer are some of the factors that
  may drive growth.

4
U.S. In-vitro colorectal cancer screening tests
market size, by test type, 2012 - 2023 (USD
Million)

5

Browse Full Market Research Report On In-vitro
Colorectal Cancer Screening Tests Market _at_
http//goo.gl/JHtO1Z Request for a Sample of
this Research Report _at_ https//www.gminsights.com/
request-sample/detail/451 https//www.gminsights.
com/request-sample/detail/49
6
360 Analysis

• Product Analysis
• Fecal occult blood tests dominated the in-vitro
  colorectal cancer screening tests market size by
  revenue, at more than USD 230 million in 2015.
  Growing incidence of colorectal cancer leading to
  high usage rate, and ease of use for screening
  large group of population has been instrumental
  in strengthening the demand for fecal occult
  blood tests.
• Regional Analysis
• North America remains the largest regional
  industry, owing to significant revenue outlay in
  the U.S., with target revenue of more than USD
  400 million by 2023. Colorectal cancer is the
  third most diagnosed cancer, and second most
  common cause of mortality amongst the cancer
  patients in the U.S. As per the statistics of
  American Cancer Society, 132,700 new colorectal
  cancer cases will be diagnosed in 2015.
• Competitive Market Share
• Global in-vitro colorectal cancer screening tests
  market share is highly competitive and marked by
  frequent mergers and acquisitions, strategic
  alliances, collaborations to widen product
  portfolio. Some of the dominant players include
  Abbott Molecular, Alere, Beckman Coulter, Eiken
  Chemical, and Siemens Healthcare.

7
Stay In Touch Website www.gminsights.com Soci
al Media